Conditions: Non-small Cell Lung Cancer
Keywords: Lung cancer Non-small cell lung cancer Tarceva Radiotherapy Local-regionally advanced non-small cell lung cancer
Allocation: NA | Intervention model: SINGLE_GROUP
Enrollment: 15
Healthy volunteers: no

Brief summary:
The trial is a phase II study of daily Tarceva combined with definitive radiotherapy in inoperable locally advanced non small cell lung cancer (stage IIB-IIIB). The objective of the phase II trial is to examine Tarceva concomitant with curatively intended irradiation 66 Gy (2 Gy x 33 F, 5 F per week).

Detailed description:

Arms:
arm 1: None

Interventions: intervention 1: Tarceva intervention 2: Radiotherapy
Intervention descriptions: intervention 1: Tarceva 150 mg/day intervention 2: 66 Gy/33 F/5 F per week for 5 weeks

Protocol document: